Information services provider Thomson Reuters, US, has announced that Micromedex 2.0, the new web-based version of its market-leading clinical information system, is now available to current and new customers. Micromedex 2.0 gives clinicians direct web and mobile access to Micromedex content through a new user interface that combines enhanced search with user-based interface design to simplify and enhance the way they use referential information.
Pharmacists, nurses, and physicians in more than 3,500 hospitals in 83 countries use Micromedex for evidence-based information on drugs, disease management, toxicology, neonatal dosing, and alternative medicines as well as patient education material. Micromedex 2.0 was designed to help clinicians make better use of this wealth of information. New features include an interface based on clinician workflow patterns, enhanced search capabilities, special tabs for high-usage tools, and compatibility with iPhone, iPod Touch, BlackBerry smartphones, and other mobile devices.
New search functionality allows for multi-term search, predictive text, synonyms and suggestions for alternate spellings. Highly used features — such as dosing calculators, Trissel’s 2 IV compatibility, drug identification, and drug interaction checking — have been pulled into separate tabs so they can be accessed and used quickly. Micromedex 2.0 also simplifies how clinicians see results. The new 360-degree view of results provides a complete picture of all available information about a drug or condition on a single screen — including drug summaries, images, consults, comparative efficacy information, labeled and off-label indications, treatment options, and more.
The Micromedex 2.0 is available at no additional charge for existing Micromedex customers.
Search for more decision support tools
Discuss this NEWS
